Clinical Trial

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Name: A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM — clinical trial record (NCT06976606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SNAPSHOT- PKP2

Recruiting

View on ClinicalTrials.gov →

Summary

An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.

Trial Details

NCT Number	NCT06976606
Lead Sponsor	Lexeo Therapeutics
Conditions	Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC
Enrollment	40 participants
Start Date	2024-01-23
Primary Completion	2027-07 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-05-16